Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Koji Urakami is active.

Publication


Featured researches published by Koji Urakami.


Journal of Chromatography A | 2010

Charge heterogeneity of a therapeutic monoclonal antibody conjugated with a cytotoxic antitumor antibiotic, calicheamicin.

Eiki Maeda; Koji Urakami; Kiyohito Shimura; Mitsuhiro Kinoshita; Kazuaki Kakehi

A robust and highly reproducible capillary isoelectric focusing (cIEF) method for the evaluation of charge heterogeneity of monoclonal antibody (mAb) pharmaceutical which contains covalently bound antitumor compounds was developed using a combination of commercially available dimethylpolysiloxane-coated capillary and carrier ampholyte. In order to optimize major analytical parameters for robust mobilization, experimental responses from three pI markers were selected. The optimized method gave excellent repeatability and intermediate precision in estimated pI values of charge variants with relative standard deviations (RSDs) of not more than 0.06% and 0.95%, respectively, when using IgG(4) as a model. Furthermore, RSDs of charge variant compositions were less than 5.0%. These results suggest that the proposed method can be a powerful tool for reproducible evaluation of charge variants of both naked mAbs and their conjugates with high resolution, and it is applicable to quality testing and detailed characterization in the pharmaceutical industry. In addition, it should be noticed that the method provided non-linear pH gradient within the tested ranges, from pI 9.50 to 3.78, and the pH gradient caused the inconsistency of estimated pI ranges between cIEF and gel IEF. This result indicates that selecting appropriate pI markers based on the target pI ranges of charge variants for each mAb related pharmaceutical is highly recommended for the precise determination of pI values.


International Journal of Pharmaceutics | 2003

A kinetic and thermodynamic study of seratrodast polymorphic transition by isothermal microcalorimetry

Koji Urakami; Anthony E. Beezer

The development of isothermal microcalorimetry to a study of the kinetic and thermodynamics of polymorphic transitions in seratrodast ((+/-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid) Form II is reported. Sieved samples of Form II were allowed to convert to Form I, in a reaction vessel of an isothermal microcalorimeter, under 13, 31, 63 and 93% relative humidity (RH) between 48 and 65 degrees C. The power (Phi, in Watts) versus time curves from the microcalorimeter were integrated into the heat output (q, in Joules) versus time curves to yield fractional extent of Form I converted versus time curves. The change in enthalpy (-5.70 kJmol(-1)) agreed very closely with that obtained by differential scanning calorimetry and solution calorimetry, which indicated that the power measured by the microcalorimeter was due only to the Form II-to-Form I transition. Application of the theoretical kinetic method [J. Am. Ceram. Soc. 55 (1972) 74] revealed that the transition took place via a two-dimensional growth of nuclei mechanism at all the studied relative humidities and temperatures. The rate constant increased with increasing RH and temperature, and with decreasing the particle size of sample. The activation energies obtained from Arrhenius plots were 292, 290, 280 and 284 kJmol(-1), and the extrapolated rate constants at 25 degrees C were also 3.01 x 10(-10), 3.11 x 10(-10), 9.65 x 10(-10) and 3.84 x 10(-9)s(-1) for 13, 31, 63 and 93% RH, respectively.


Analytical Chemistry | 2012

Analysis of nonhuman N-glycans as the minor constituents in recombinant monoclonal antibody pharmaceuticals.

Eiki Maeda; Soichiro Kita; Mitsuhiro Kinoshita; Koji Urakami; Takao Hayakawa; Kazuaki Kakehi


Journal of Chromatography A | 2004

Matrix media selection for the determination of residual solvents in pharmaceuticals by static headspace gas chromatography

Koji Urakami; Atsuya Higashi; Kazuichi Umemoto; Masayuki Godo


Chemical & Pharmaceutical Bulletin | 2002

A Novel Method for Estimation of Transition Temperature for Polymorphic Pairs in Pharmaceuticals Using Heat of Solution and Solubility Data

Koji Urakami; Yasushi Shono; Atsuya Higashi; Kazuichi Umemoto; Masayuki Godo


Archive | 2008

Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole

Koji Urakami; Keith Lorimer; Kevin Wayne Meyer; Mark Andres


Chemical & Pharmaceutical Bulletin | 2001

Compositional Analysis of Copoly (DL-Lactic/Glycolic Acid) (PLGA) by Pyrolysis-Gas Chromatography/Mass Spectrometry Combined with One-step Thermally Assisted Hydrolysis and Methylation in the Presence of Tetramethylammonium Hydroxide

Koji Urakami; Atsuya Higashi; Kazuichi Umemoto; Masayuki Godo; Chuichi Watanabe; Keiji Hashimoto


Bulletin of the Chemical Society of Japan | 2002

Estimation of transition temperature of pharmaceutical polymorphs by measuring heat of solution and solubility

Koji Urakami; Yasushi Shono; Atsuya Higashi; Kazuichi Umemoto; Masayuki Godo


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2005

A Simple Method for Quantitative Determination of Active Drug Polymorphs and Amorphous in Drug Products by Fourier Transform-Raman Spectroscopy

Takahiro Ueno; Koji Urakami; Atsuya Higashi; Kazuichi Umemoto; Masayuki Godo; Keisuke Kitamura


Thermochimica Acta | 2004

Pharmaceutical microcalorimetry: recent advances in the study of solid state materials

Anthony E. Beezer; Michael A.A. O’Neill; Koji Urakami; Joseph A. Connor; John Tetteh

Collaboration


Dive into the Koji Urakami's collaboration.

Top Co-Authors

Avatar

Atsuya Higashi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kazuichi Umemoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masayuki Godo

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keith Lorimer

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yasushi Shono

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Eiki Maeda

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kevin Wayne Meyer

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mark Andres

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge